Benichou Nicolas, Lebbah Saïd, Hajage David, Martin-Lefèvre Laurent, Pons Bertrand, Boulet Eric, Boyer Alexandre, Chevrel Guillaume, Lerolle Nicolas, Carpentier Dorothée, de Prost Nicolas, Lautrette Alexandre, Bretagnol Anne, Mayaux Julien, Nseir Saad, Megarbane Bruno, Thirion Marina, Forel Jean-Marie, Maizel Julien, Yonis Hodane, Markowicz Philippe, Thiery Guillaume, Schortgen Frederique, Tubach Florence, Ricard Jean-Damien, Dreyfuss Didier, Gaudry Stéphane
AP-HP, Hôpital Européen Georges Pompidou, Service de Néphrologie, 75015, Paris, France.
Université de Paris, Paris, France.
Ann Intensive Care. 2021 Apr 8;11(1):56. doi: 10.1186/s13613-021-00843-3.
Vascular access for renal replacement therapy (RRT) is routine question in the intensive care unit. Randomized trials comparing jugular and femoral sites have shown similar rate of nosocomial events and catheter dysfunction. However, recent prospective observational data on RRT catheters use are scarce. We aimed to assess the site of RRT catheter, the reasons for catheter replacement, and the complications according to site in a large population of critically ill patients with acute kidney injury.
We performed an ancillary study of the AKIKI study, a pragmatic randomized controlled trial, in which patients with severe acute kidney injury (KDIGO 3 classification) with invasive mechanical ventilation, catecholamine infusion or both were randomly assigned to either an early or a delayed RRT initiation strategy. The present study involved all patients who underwent at least one RRT session. Number of RRT catheters, insertion sites, factors potentially associated with the choice of insertion site, duration of catheter use, reason for catheter replacement, and complications were prospectively collected.
Among the 619 patients included in AKIKI, 462 received RRT and 459 were finally included, with 598 RRT catheters. Femoral site was chosen preferentially (n = 319, 53%), followed by jugular (n = 256, 43%) and subclavian (n = 23, 4%). In multivariate analysis, continuous RRT modality was significantly associated with femoral site (OR = 2.33 (95% CI (1.34-4.07), p = 0.003) and higher weight with jugular site [88.9 vs 83.2 kg, OR = 0.99 (95% CI 0.98-1.00), p = 0.03]. Investigator site was also significantly associated with the choice of insertion site (p = 0.03). Cumulative incidence of catheter replacement did not differ between jugular and femoral site [sHR 0.90 (95% CI 0.64-1.25), p = 0.67]. Catheter dysfunction was the main reason for replacement (n = 47), followed by suspected infection (n = 29) which was actually seldom proven (n = 4). No mechanical complication (pneumothorax or hemothorax) occurred.
Femoral site was preferentially used in this prospective study of RRT catheters in 31 French intensive care units. The choice of insertion site depended on investigating center habits, weight, RRT modality. A high incidence of catheter infection suspicion led to undue replacement.
在重症监护病房中,肾脏替代治疗(RRT)的血管通路是一个常规问题。比较颈内静脉和股静脉置管部位的随机试验表明,医院感染事件和导管功能障碍的发生率相似。然而,近期关于RRT导管使用的前瞻性观察数据较少。我们旨在评估RRT导管的置管部位、导管更换的原因以及在大量急性肾损伤重症患者中根据置管部位出现的并发症。
我们对AKIKI研究进行了一项辅助研究,AKIKI研究是一项实用的随机对照试验,在该试验中,患有严重急性肾损伤(KDIGO 3级分类)且接受有创机械通气、使用儿茶酚胺或两者皆有的患者被随机分配至早期或延迟RRT启动策略组。本研究纳入了所有接受至少一次RRT治疗的患者。前瞻性收集RRT导管的数量、置管部位、可能与置管部位选择相关的因素、导管使用时长、导管更换原因及并发症。
在AKIKI研究纳入的619例患者中,462例接受了RRT,最终纳入459例,共使用了598根RRT导管。优先选择股静脉置管(n = 319,53%),其次是颈内静脉(n = 256,43%)和锁骨下静脉(n = 23,4%)。多因素分析显示,持续RRT模式与股静脉置管显著相关(OR = 2.33(95%CI(1.34 - 4.07),p = 0.003),体重较高与颈内静脉置管相关[88.9 vs 83.2 kg,OR = 0.99(95%CI 0.98 - 1.00),p = 0.03]。研究人员所在地点也与置管部位的选择显著相关(p = 0.03)。颈内静脉和股静脉置管部位的导管更换累积发生率无差异[sHR 0.90(95%CI 0.64 - 1.25),p = 0.67]。导管功能障碍是更换导管的主要原因(n = 47),其次是疑似感染(n = 29),但实际很少得到证实(n = 4)。未发生机械并发症(气胸或血胸)。
在法国31个重症监护病房进行的这项RRT导管前瞻性研究中,优先选择股静脉置管。置管部位的选择取决于研究中心的习惯、体重、RRT模式。导管感染疑似发生率高导致了不必要的更换。